Clover Health Investments (CLOV) Tops Q3 EPS by 4c

Clover Health Investments (NASDAQ: CLOV) reported Q3 EPS of ($0.16), $0.04 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $856.8 million versus the consensus estimate of $804.04 million.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• Magnificent 7 stocks lose $2.3 trillion in June
• NexPoint Residential Trust (NXRT) PT Lowered to $26 at Truist Securities
• Merck (MRK) PT Raised to $155 at Scotiabank